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Abstract
Single base substitutions constitute the most frequent type of human gene mutation and are a leading cause of cancer and
inherited disease. These alterations occur non-randomly in DNA, being strongly influenced by the local nucleotide sequence
context. However, the molecular mechanisms underlying such sequence context-dependent mutagenesis are not fully
understood. Using bioinformatics, computational and molecular modeling analyses, we have determined the frequencies of
mutation at GNC bp in the context of all 64 59-NGNN-39 motifs that contain the mutation at the second position. Twenty-four
datasets were employed, comprising .530,000 somatic single base substitutions from 21 cancer genomes, .77,000
germline single-base substitutions causing or associated with human inherited disease and 16.7 million benign germline
single-nucleotide variants. In several cancer types, the number of mutated motifs correlated both with the free energies of
base stacking and the energies required for abstracting an electron from the target guanines (ionization potentials). Similar
correlations were also evident for the pathological missense and nonsense germline mutations, but only when the target
guanines were located on the non-transcribed DNA strand. Likewise, pathogenic splicing mutations predominantly affected
positions in which a purine was located on the non-transcribed DNA strand. Novel candidate driver mutations and tissue-
specific mutational patterns were also identified in the cancer datasets. We conclude that electron transfer reactions within
the DNA molecule contribute to sequence context-dependent mutagenesis, involving both somatic driver and passenger
mutations in cancer, as well as germline alterations causing or associated with inherited disease.
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Introduction
At least fifteen cancer genome sequencing projects were
reported between 2007 and 2011 [1–15], and this number is
now increasing very rapidly. These studies have been critical for
addressing mechanisms of somatic mutation, such as those
associated with single base substitutions (SBSs), which not only
represent the vast majority of lesions in most patients, but also (in
the case of some driver mutations) alter gene function, thereby
initiating tumor development. Such investigations have demon-
strated that SBSs do not occur randomly throughout the genome.
Indeed, frequent CRT transitions have been noted at CpG
dinucleotides [4,9,16–18], which are attributable to the high rate
of spontaneous 5-methylcytosine (5mC) deamination at methylated
5mCpG sites [19,20]. In individuals with a history of exposure to
cigarette smoke or radio/chemotherapy, high proportions of
GRT transversions, GRA and GRC substitutions at GpA and
CpG dinucleotides, and ART and ARG substitutions at TpA
dinucleotides have also been reported [6,8,9,21], suggestive of
DNA damage through exogenous mechanisms [22,23]. Likewise,
large numbers of CRT transitions at YpC (Y = C/T) dinucleo-
tides in melanoma in sun-exposed areas of the skin [11,21,24] have
been attributed to cyclobutane pyrimidine dimer (CPD) formation
following UV photoexcitation [25]. For less common types of
substitution, such as TRC at ApT dinucleotides in hepatocellular
carcinoma [16], underlying mutational mechanisms have yet to be
proposed.
Studies aimed at identifying the mechanisms underlying the
sequence context dependency of SBSs observed in inherited
disease [26], cancer and phylogenetic analyses [20,27–31] are few
in number. A recent analysis of breast cancer genomes identified
five types of trinucleotide motif enriched in SBSs, all of which
contained either a CpG or a GpA motif [18]. Substitutions at CpG
were attributed to 5mCpG deamination, whereas mutations at the
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GpA motif, which displayed sporadic clustering, were linked to
enzymatic deamination of C at TpC by TC-specific cytosine
deaminases [18]. Cluster analyses in other types of cancer led
Roberts et al. to propose a similar mechanism for mutations at
GpA sequences [32]. Indeed, recent work has identified
APOBEC3B as a likely enzymatic source of CRT transitions
in breast cancer [33]. In melanoma, Krauthammer et al.
reported an enrichment of mutations at C in the context of 59-
TTTCGT-39 motifs, a finding which was attributed to energy
transfer along the pyrimidine-rich strand upon UV exposure
[34]. Thus, although the influence of flanking bases on SBSs
appears to extend beyond dinucleotide units, substantial gaps
remain in our understanding of the mutational mechanisms
involved. Elucidating these mechanisms is crucial, not only
because they provide critical information on the earliest steps of
cancer-associated mutagenesis, but also because they may
account for inter-individual genetic variation as well as somatic
age-related changes within the same individual.
Herein, we analyzed the frequencies of mutation at GNC bp in
the context of all possible 4-bp 59-NGNN-39 units from .530,000
SBSs representing 21 cancer genomes, .77,000 germline muta-
tions causing or associated with human inherited disease and 16.7
million benign germline single nucleotide variants (SNVs). The 64
combinations of 59-NGNN-39 motifs provided a suitable set size
that was not too large to hamper sequence representation while
doubling the length of base interactions relative to the commonly
employed dinucleotide sequences [35]. In several cancer mutation
datasets, but also in the germline mutations, the frequencies of
substitutions correlated with the free energy of base stacking along
the G-containing strand, as well as with ionization potentials, i.e.
the energy required for abstracting an electron from the target
guanines. Such behavior is consistent with an electron transfer
mechanism as a consequence of one-electron oxidation reactions
between the DNA molecule and radical species in the cell
[22,36,37]. We conclude that electron transfer contributes to
sequence context-dependent SBSs, not only in the context of
cancer genomes but also in pathogenic germline mutations.
Results
SBSs Occur Preferentially at GNC Base-Pairs (bp)
We collected the publicly available data from cancer genome
studies reported in PubMed between 2007 and 2011, together
with the 5 largest datasets from the International Cancer Genome
Consortium (ICGC) (Table 1). Twenty-one datasets, 13 from
exome-wide (EWS) and 8 from genome-wide (GWS) sequencing
scans, together represented cancers from 14 different tissues
comprising 1,149 patient samples (1 to 393 samples per dataset)
and 2 cell lines, for a total of 533,482 SBSs (Table S1). Additional
SBSs from 3 other datasets were included in the analysis: a subset
of nonsense and missense germline mutations of pathological
significance in the context of inherited disease derived from the
Human Gene Mutation Database (HGMD); a subset of splicing
mutations from HGMD causing human inherited disease; and the
set of SNVs from the ‘‘1000 Genomes Project’’ included in dbSNP
build 129 (‘‘rs’’ set), to allow direct comparison of the cancer-
associated somatic mutations with germline mutations and
polymorphisms present in the general population. The median
fractions of SBSs that occurred at GNC bp were 0.78 (mean 6 SD,
0.7560.11) for the EWS datasets and 0.56 (mean 6 SD,
0.6060.13) for the GWS datasets (Fig. 1A), significantly higher
than the average GC-content exome-wide (0.55) [38] and genome-
wide (0.41), respectively [39] (both P values were ,2.2610216, the
smallest computable number by implementation of the binomial
exact test in R). Thus, SBSs occurred more frequently at GNC bp,
as compared to ANT bp, than expected by chance alone, both in
cancer genomes and in the germline as a cause of inherited
disease.
SBS Frequencies Are Modulated by Flanking Base
Composition
We addressed the sequence-dependent occurrence of SBSs at
GNC bp by retrieving the 59-NGNN-39 and their complementary
59-NNCN-39 sequences (henceforth referred to as NGNN), either
genome-wide or exome-wide, and calculating the fractions of
mutated motifs, f(NGNN), for each of the 64 sequence combina-
tions. There were two confounding factors in computing
f(NGNN): the first related to the fact that only certain portions
of the human genome may be effectively mapped by next-
generation sequencing; the second originating from the various
methodologies used during base-variant mapping and calling (see
Materials and Methods). Therefore, we first assessed the relative
representation of NGNN sequences in the homologous portions
(Segmental Duplications, repetitive elements and simple repeats)
as compared with the unique portions of the human genome (Text
S1 and Table S1). These analyses indicated that CGNN motifs are
significantly overrepresented in Segmental Duplications (Text S1
and Table S2). We then used the genomic mutation sites (Table
S3) to compute f(NGNN) according to three methods (Duke35,
CRG50 and T_hg19) for the GWS datasets and three methods
(AgilentV2, CGR50_exons and T_exons) for the EWS datasets
(Text S1), and used these fractions to assess the extent to which
base composition at positions 1, 3 and 4 (P1, P3 and P4) would
influence GNC mutations at position 2 (P2) for different classes of
NGNN sequences. Mutations were observed at each NGNN
sequence combination with the exception of the two small
colorectal cancer datasets (Table 1; Table S4, Panel A). Thus,
for these two datasets, z-tests, rather than t-tests, were used to
assess statistical significance. Irrespective of the mapping method
used, f(CGNN) mean values were significantly greater than
f(DGNN) (D = A/G/T) mean values in all cancer (2–11 fold,
depending on cancer type with gastric and colorectal cancers
Author Summary
A large number of DNA mutations identified in cells from
patients with cancer or human inherited disease were
analyzed to address a fundamental issue in human
pathology, viz, the mutational mechanisms that cause
irreversible changes to DNA. By using bioinformatics and
computational methods, we found that mutations do not
occur randomly, but instead affect specific bases, most
often guanines flanked by other guanines or adenines. We
attribute this effect to electron transfer, a chemical
reaction known to underlie basic biological processes
such as cellular respiration and photosynthesis. Certain
types of carcinogens, oxidants or radiation can interact
with DNA and abstract an electron. Our results imply that
the ensuing sites of electron loss can migrate from their
original position in the DNA to neighboring guanines
where they become trapped, leading to further chemical
modifications that may eventually result in mutations.
Many of the mutations known to be important for tumor
growth (driver mutations), as well as passenger mutations
and mutations associated with inherited disease, appear to
be caused by electron transfer. Beyond pathological
mutations, electron transfer may represent a universal
mechanism by which genetic changes occur in all life
forms to drive population fitness over evolutionary time.
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displaying the largest differences) and germline mutation datasets
(Table S4, Panels B–D), with 2logP values ranging from 8 (Breast;
9.363.361025 for CGNN vs. 4.062.661025 for DGNN,
AgilentV2 counts) to 41 (1000GP; 6.961.361022 for CGNN vs.
7.561.561023 for DGNN, CRG50 counts) (Table 1). Exceptions
were the two Melanoma datasets, for which such differences were
modest due to considerable variability in the data (2.263.461024
for CGNN vs. 0.961.261024 for DGNN, P-value 0.02 for
Melanoma_ews, AgilentV2 counts; 4.967.561025 for CGNN vs.
2.462.861025 for DGNN, P-value 0.06 for Melanoma_gws,
Duke35 counts). Thus, with the notable exception of the
melanomas, the CpG dinucleotide, a substrate for cytosine
methylation, represents a strong mutation hotspot, both in the
soma and the germline.
For the DGNN sequences, a P3-purine significantly increased
the proportions of P2 SBSs, f(DGRN), compared to a pyrimidine,
f(DGYN) in 7 cancer types (2logP values 3–9), including lung,
head and neck, and melanoma (Table 1), for which associations
with exposure to either cigarette smoke or sunlight have been
documented. An additional dataset, Lung_sc, from the established
cell-line NCI-H209 displayed modest f(DGRN).f(DGYN)
(P-value ,0.04). Again, in no cases were P-values contradictory
based upon the mapping method used (Table S4, Panels B–D).
The data for the melanomas were particularly striking since P3-A
increased the fractions of mutation at P2-G by ,10-fold relative to
DGBN (B = C/G/T) (14.3 vs. 1.761025 for Melanoma_gws, P-
value 9.161024; and 68.4 vs. 6.461025 for Melanoma_ews, P-
value 2.461025; according to Duke35 and AgilentV2, respective-
ly, Table S5). In addition, the CGAN motifs displayed ,3-fold
higher mutation fractions than the DGAN motifs (14.3 vs.
4.961025, P-value 0.019; and 68.4 vs. 20.561025, P-value
2.861023) in Melanoma_gws and Melanoma_ews, respectively,
although a mutagenic role for CpG methylation was not apparent
(i.e. the CGBN and DGBN fractions were indistinguishable, P-
values ,0.6–0.7). In addition, for the two melanoma datasets, P4-
A significantly increased (2.260.2 fold) mutation at P2-G (Fig. 1B)
when P2 and P4 were separated by a purine (P-value 5.661027).
Additional analyses in four melanoma datasets [17,21,34,40]
confirmed this finding (ratio for the eight possible NGRA/NGRB
groups in these four datasets was 2.260.5 and 2.260.3 for the
combined six datasets, Table S6). The increase in mutation at P2-
G, relative to P4-C and P4-T, was also observed for P4-G;
Figure 1. SBSs and VIPs. Panel A, whisker plot of the fractions of SBSs at GNC bp for the EWS and GWS datasets computed using AgilentV2 and
Duke35 mappability counts, respectively; red line, mean; black line, median; green lines, average GC-contents in the mappable AgilentV2 (EWS) and
Duke35 (GWS) sets. Panel B, NGRA sequences are enriched in SBSs in melanoma. y-axis, for each 4-member sequence combination with matching P1–
P3 bases, the fraction of mutations at P4-A was divided by the average fraction of mutations at P4-(C/T/G); x-axis, P3 base composition; R, purine; Y,
pyrimidine; mean 6 SD; P-value from two-tailed t-test. Panel C, the ln of normalized fractions of mutated DGNN (D = A/G/T) sequences, Fi, for the
seven cancer datasets with 2logP $3 for DGRN.DGYN (Table 1) were combined and plotted as a function of the average absolute free energy of
base stacking, DG(n), for each of the 48 DGNN sequences. Panel D, three-dimensional model of the (59-GGG-39)N(59-CCC-39) trinucleotide showing the
LUBMO (lowest unoccupied beta molecular orbital) of the ionized sequence. Panel E, plot of the normalized fractions (log fi610
3) of mutated DGN
sequences (Duke35 counts) for the Lung_nsc cancer dataset vs. VIPs; outer circle, 59D base; inner circle, 39N base; blue, adenine; green, guanine; red,
thymine; yellow, cytosine. Panel F, agglomerative hierarchical clustering of 14 cancer genome datasets obtained from linear correlations with ln VIP
values, as obtained from T_hg19 counts; colored boxes, elements found to be clustered at the 90% confidence interval.
doi:10.1371/journal.pgen.1003816.g001
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however, this effect was less consistent than P4-A and was
observed more frequently when P3 was occupied by a guanine
(18/23 cases) rather than an adenine (5/23 cases), Table S6.
In summary, SBSs at P2-G were dependent upon the sequence
composition of the 39-nearest neighbor in a number of different
cancer types; in melanoma, this effect extended to the next 39 base
when bridged by a purine. Thus, GpR and GpRpA sequences
constitute mutational hotspots that render the 59 G sensitive to
mutation. Further analyses performed in individual cancer
samples (Text S1, Figure S1 and Table S4, Panels B–E) indicated
that biological mechanisms, rather than differences in variant-
calling algorithms or variability between individual samples, were
the likely causes of such mutational patterns.
Electron Transfer and Sequence-Dependent SBSs
Guanine is the most readily oxidized base [41] and its ionization
energy, i.e. the energy required to abstract an electron, depends
upon the identity of the flanking nucleotides [42–45]. Substantial
work performed with model DNA sequences in vitro has shown
that, following one-electron oxidation reactions, the sites of
electron loss (hole) migrate efficiently (rate constants ,107 s21)
from the original locations to distant sites, where they become
trapped in troughs of low ionization energy, most often at GG and
GGG sequences [36,44,46–48]. Because oxidative DNA damage
occurs spontaneously in the cell, we tested whether the sequence-
dependent SBS patterns were consistent with a mutagenesis model
that included: a) loss of an electron within the NGNN sequences;
b) hole migration to the P2-guanine; and c) chemical modification
of the P2-guanines leading to base substitutions [22].
Absolute Free Energy of Base Stacking
The binding energy of single-stranded stacked bases is
presumed to be dependent upon the affinity of interactions, or
the extent of electron sharing, between p orbitals across bases
[49]. The free energy of base stacking, rather than hydrogen
bonding, has been reported to be the major source of stability in
duplex DNA [50]. Hence, we expected that strongly interacting
bases would be more prone to one-electron oxidation and,
hence, to higher SBS rates than weakly interacting bases. To
this end, we used the absolute free-energy values of base
stacking between non-bonded bases, DG(n), derived from a
theoretical study [51] using a continuum solvation model and
Amber force field to assess the relationships with f(DGNN)
values, as we previously employed [52]. For 5/7 datasets with
f(DGRN).f(DGYN) (Table 1), i.e. two melanomas, Lung_nsc,
Liver_riken and Mixed, a significant positive correlation existed
between the fraction of mutated DGNN sequences and free
energies of base stacking (Table S7, Panel A; r2 0.10–0.71; P-
values ,0.001–0.031). The normalized mutation fractions for
the combined 7 datasets also displayed significant correlation
(r2 0.47; P,0.001; P(a)0.05 = 1.000; Fig. 1C and Table S7, Panel
A; f(DGNN) were according to Duke35 and AgilentV2
mappability).
Vertical Ionization Potentials (VIPs)
VIP, the minimum energy required to abstract an electron, is
commonly used as a measure of one-electron oxidation reactivity
[41]. We modeled the susceptibilities of G-centered DGN double-
stranded trimers to oxidation via quantum chemical computations
of VIPs. These analyses are expected to compare favorably with
data obtained from the computationally more demanding
tetramers; the VIPs for tetramers would be expected to be lower
than for trimers while maintaining similar sequence-dependent
rankings for P2 [53–56]. The VIP values for the 12 trimers were
,30–40% lower than that of an isolated guanine (Table 2) whose
VIP estimate was close to the experimentally determined lowest
band maximun [57]. The trimer with the lowest VIP was GGG, in
agreement with prior calculations [42–45] and all trimers
containing a GG doublet had lower VIPs than those with a single
G. In addition, a purine at the 39 position was consistently
associated with lower VIPs than a pyrimidine at the 39 position.
Thus, DNA sequence context affects VIPs, in accordance with
guanine reactivities to oxidative reactions in vitro [42,44].
Inspection of the lowest unoccupied beta molecular orbital
(LUBMO) for each DNA trimer cation, [DGN]+, in which the
ionization state was modeled by removing an electron, showed
that the electron hole invariably had p character with high
densities at the central guanine (Fig. 1D), or at the 59G in the
GGH (H = A, C, T) sequences, consistent with previous work
[42,55,56,58,59], implying that P2G was a frequent site for one-
electron oxidation reactions. Analyses between f(DGN) and VIP
values displayed significant correlations for 4/5 datasets that
also revealed a correlation with DG(n), i.e. melanomas,
Lung_nsc and Liver_riken (as per Duke35 and AgilentV2
mappability; Figure 1E, Figure S2 and Table S7, Panel B; r2
0.54–0.75; P-values,0.001–0.007). Notably, robust correlation
was also evident when the f(DGN) data from all 18 cancer
datasets were normalized and then computed as average values
(Table S7, Panel B and Figure S2, Panel D, r2 0.40; P-value
0.026; P(a)0.05 0.615). The regression coefficients obtained using
the T_hg19 and T_exons mappability data for the datasets with
.2,000 SBSs were also used to perform hierarchical clustering
based on absolute Manhattan distances (Fig. 1F). At a .90%
confidence interval, this yielded three clusters, the largest of
which contained the same cancer datasets, with the exception of
Ovarian carcinoma, that also displayed f(DGRN).f(DGYN)
ratios (Table 1). In summary, both base stacking and VIP data
support the conclusion that electron transfer in DNA represents
Table 2. Vertical ionization potentials (VIPs) of guanine-
centered DGN sequences.















VIPs for the centrally (italicized) guanine computed at the M06-2X/6-31G(d)
level of theory;
aVIP of free unalkylated guanine;
bfrom reference [57].
doi:10.1371/journal.pgen.1003816.t002
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a significant mechanism for sequence context-dependent muta-
genesis in cancer.
Sequence-Dependent SBSs in Cancer-Associated Genes
Driver mutations include non-synonymous (NS) substitutions
that play a key role in cancer initiation and progression. To assess
whether bona fide driver mutations also occurred in a sequence
context-dependent manner, we examined the NS substitutions that
altered the same genomic coordinate in more than one patient
sample, and the genes affected (Text S1, Figure S3 and Table S8).
For the 224 recurrent NS substitutions at GNC bps, we calculated
the relative enrichment E for each of the 64 NGNN motifs, a value
which is expected to approximate to 1 if the base substitutions are
completely independent of flanking sequence. E values were
greater for the CGNN than for the DGNN (D = A/G/T)
sequences (Figure 2, Panel A). Among the DGNN sequences,
P3-purines were associated with significantly more mutations than
P3-pyrimidines, a difference that was attributable to the presence
of P3-A (DGAN.DGBN, B = C/G/T). This trend remained
unaffected after the 45 entries from the two melanoma datasets
[which showed f(DGAN).f(DGBN) in the respective EWS
and GWS screens (Figure 1, Panel B)] were removed
(E(DGAN) = 0.9260.52; E(DGBN) = 0.3960.43; P = 0.001).
Thus, recurrent NS substitutions occurred preferentially at CpG
and GpA dinucleotides in cancer genomes, mirroring the sequence
context-dependent pattern of SBSs observed both genome-wide
and exome-wide (Figure 1 and Table 1). Of the 18 codon changes
that recurred .12 times, 7/10 affected NGNN sequences and 5/
10 occurred at CGNN sequences, all in well-established cancer
genes (Table S9, Panel A). Likewise, the most commonly mutated
CGNN (Table S9, Panel B) and DGAN (Table S9, Panel C) motifs
affected known driver mutations, alongside several novel candidate
genes and driver mutations (Table S9), including p53R248G, which
has been reported to alter protein function (http://www-p53.iarc.
fr), and GRHL3, WNK3, EPHB1, ADCY2, GSK3B and LRRN3,
which are not currently listed in the cancer gene census (http://
www.sanger.ac.uk/genetics/CGP/Census).
Tissue Distribution and Networks Affected
To examine whether recurrent NS substitutions occurred
equally in all tumor tissue types, we determined the relative
distributions of the most frequently mutated genomic coordinates
after normalizing for both tissue representation and the total
number of SBSs per dataset; in the absence of any bias, each tissue
would contribute 12.5%. The four genes with $12 recurrently
mutated genomic coordinates (TP53, KRAS, PIK3CA and BRAF)
(Table S9, Panel A) were predominantly of breast (34%), intestine
(24%) and lung (18%) origin (Figure 2, Panel B). The three most
commonly mutated CGNN sequences (CGTC, CGGA and
CGTG; S = 9.5, 6.0 and 5.7, respectively) were found in genes
mutationally altered in the intestine (26%), ovary (19%) and breast
(15%), whereas the most commonly mutated DGAN sequences
(TGAT, GGAA and TGAA; S = 2.8, 2.0 and 2.0, respectively)
were found predominantly in genes altered in melanoma (37%),
breast and lung (17% each) (Table S9). By contrast, these mutated
motifs were underrepresented in the liver (#2%). Of the 64 codons
affected, 6 (3 in TP53, 2 in PIK3CA and 1 in GNAS) are known
driver mutations, 4 introduced stop codons into TP53, and 26
occurred within genes whose involvement in cancer is strongly
suspected (Table S9 and http://www.sanger.ac.uk/genetics/
CGP/Census). Thus, although high-confidence driver mutations
occurred preferentially at CGNN and DGAN motifs, their
occurrence between tissues was highly asymmetrical, with DGAN
mutations occurring predominantly in tumors of the skin.
Finally, we used pathway analyses to survey the 150 recurrently
mutated genes (Figure 2, Panel C). In all tumor tissues, 18
pathways/networks related to cell-cycle checkpoints and the DNA
damage response were found to be compromised in all types of
tumor, the sole exception being melanomas in which only the
MAP kinase signaling pathway was consistently altered. A similar
pattern was revealed when all NS substitutions were analyzed,
irrespective of whether the data from all patients were merged
(Figure S4, Panel A) or plotted separately (Figure S4, Panels B and
C). The highest-ranking pathways were dominated by TP53
mutations in most tumor types (Figure S4, Panels B and C), with
the exception of pancreatic cancers in which KRAS mutations
dominated. Both p53 and KRAS proteins are known to act on
parallel signaling cascades that regulate TERT, the active
reverse transcriptase component of telomerase that controls the
stability of chromosome ends (http://www.biocarta.com/
pathfiles/h_telPathway.asp). Hence, although critical pathways
represent common targets for oncogenic transformation, the
altered genes may vary between different patients or organ/
tissue types. In summary, a distinction emerged between
melanoma and the other types of cancer, both with regard to
the sequence contexts targeted by driver mutations, DGAN vs.
CGNN sequences, and to the pathways that hosted these
mutations, MAP kinase vs. p53-associated signaling pathways.
Guanine Is Preferentially Targeted by Pathogenic
Germline Mutations
In the HGMD missense/nonsense mutation dataset, approxi-
mately 68% of SBSs occurred at GNC bps, a proportion similar to
the EWS cancer datasets, although correlations with DG(n) or
VIPs were absent (Table S7, Panel B) and no enrichment for
DGRN sequences was apparent (Table 1). However, r(DGNN),
which measured the fraction of mutated DGNN motifs relative to
the direction of transcription, revealed that the P2 position was
more likely to contain a guanine on the non-transcribed strand,
relative to the transcribed strand, when stacking interactions with
neighboring bases were high (r2 0.32; P-value,0.001; P(a)0.05
0.991; Figure 3, Panel A). No such behavior was evident in the
cancer datasets (not shown), whereas limited bias was observed in
the 1000 Genomes Project dataset (Figure 3, Panel A). Thus,
transcription led to a pattern of sequence context-dependent SBSs
among pathogenic germline mutations, which mirrored that
observed in several cancer genomes.
The HGMD dataset of inherited splicing mutations contained
9,907 SBSs that may be assumed to adversely affect RNA
processing; 8,308 (84%) of these mapped to within 5 bases of
donor and acceptor splice junctions (Figure 3, Panel B).
Strikingly, although the canonical GT and AG intronic splice
junctions at the donor AG‘GTAAGT and acceptor CAG‘GT
sequences were found to be .99.9% conserved in the RefSeq
dataset of human genes (Figure S5 top), only three positions, i.e.
AG‘GTAAGT and CAG‘GT, were frequently mutated (1,297–
2,601 SBSs, 65%), the T-containing donor position being only
modestly affected (836 SBSs). We also used the 1000 Genomes
Project dataset to assess the extent of splicing variation in the
general population (Figure S5 middle); the smallest number of
SNVs occurred at all 4 highly conserved positions, as expected.
By contrast, in the cancer datasets, the number of SBSs around
splice junctions was found to be independent of sequence
conservation (Figure S5 bottom). In summary, pathological germ-
line splicing mutations preferentially targeted those positions that
exposed a purine base to the non-transcribed strand during DNA
transcription.
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Discussion
Large-scale next-generation sequencing projects of cancer
genomes are providing an unprecedented opportunity to address
the key issue of the nature of the underlying mechanisms of base
substitution in tumorigenesis. This issue is generally approached
by analyzing the types of base substitution specific to the cancer
tissue, i.e. mutation spectra, based on the assumption that different
types of base substitution originate via different mutational
mechanisms, as assessed by animal model systems [4,6,8,9,16–
18,21,60–63]. We have chosen the alternative approach of
addressing the sequence-context dependency of single base
substitution, with the expectation of shedding light on the earliest
step(s) in the process of mutagenesis, i.e. the susceptibility of DNA
to base modification. Once modified, a base would then undergo
various types of substitution based upon the type of modification it
incurred, its interactions with DNA repair and replication systems
and, possibly, the tissue of origin [62].
As revealed by correlations with VIPs and absolute free energies
of base stacking, we uncovered a direct correlation between
electronic coupling along the DNA chain, leading to electron
transfer, and sequence-dependent SBSs, both in human cancers
and as a cause of inherited disease. Thus, charge transfer appears
to be the earliest event in the mutational mechanism acting along
Figure 2. Recurrent NS substitutions display sequence context-dependent patterns of mutation. Panel A, relative enrichment, Ei, of
NGNN sequences carrying NS substitutions that recurred in different patient samples in all cancer types. CGNN, the 16 motifs beginning with a CpG
step; DGNN, the 48 motifs not beginning with a CpG step; DGRN, the 24 motifs with a purine following the mutated G; DGYN, the 24 motifs with a
pyrimidine following the mutated G; DGAN, the 12 motifs with an adenine following the mutated G; DGBN; the 36 motifs without an adenine
following the mutated G; mean 6 SD. Panel B, distribution of the top recurrently mutated genomic positions across the most abundant cancer types;
top $10, ANT- and GNC-containing hg19 coordinates flanked by any sequence and mutated at least ten times (range 10–40 times, 16 coordinates); top
CGNN, the three most commonly mutated CGNN sequences (CGTC, Ei = 9.55, 13 coordinates; CGGA, Ei = 5.99, 10 coordinates; and CGTG, Ei = 5.66, 10
coordinates); top DGAN, the three most commonly mutated DGAN sequences (TGAT, Ei = 2.79, 10 coordinates; GGAA, Ei = 2.04, 10 coordinates; TGAA,
Ei = 1.97, 10 coordinates), see also Table S9. For each cancer type with at least 1000 NS substitutions, the fraction S was plotted on the pie charts.
Panel C, pathway-level heatmap with the clustering of commonly hit pathways containing genes with recurrent NS substitutions amongst all tumor
types. Number of hits, number of genes belonging to the same pathway or network.
doi:10.1371/journal.pgen.1003816.g002
Mechanisms of Mutation and Human Genetic Disease
PLOS Genetics | www.plosgenetics.org 7 September 2013 | Volume 9 | Issue 9 | e1003816
the path leading to base substitution in cancer. Electron transfer is
the simplest chemical reaction and is known to underlie a number
of fundamental biological processes such as cellular respiration and
photosynthesis. By establishing the relevance of charge transfer to
mutational changes in the DNA molecule, our study enables
improved predictions of the relative contribution of individual
mutagenic processes and DNA repair activities to cancer
(Donohue et al., unpublished data). The somatic and germline
settings studied here are qualitatively and quantitatively different
and quite distinct from one another. In the former, very large
numbers of somatic mutations occur as a consequence of the
disease state whereas in the latter, only one or two germline
mutations are generally involved in disease etiology. Despite these
fundamental differences, similar sequence context-dependencies
are evident, which are explicable in terms of the intrinsic physical
properties of DNA, i.e., free energy of co-axial base stacking and
electronic coupling among flanking bases. We propose a model for
SBSs that includes one-electron oxidation reactions (Figure 3,
Panel C). In the first step, abstraction of an electron from DNA
(base or sugar) by a radical species, either endogenous or
exogenous, creates an electron hole. In the second step, the
electron hole migrates reversibly to various competing sites,
including flanking or more distant bases, as well as other molecules
and contacting chromatin-associated amino acids, causing in some
instances DNA-protein crosslinks [64]. Guanines with the lowest
ionization potentials, as determined by neighboring bases, are the
strongest hole-attracting sites. The resulting radical cations (GN+)
are then expected to undergo a number of chemical modifications,
leading to a variety of stably modified bases, including 8-oxoG, a
key toxicological lesion, oxazolone, imidazolone and others, some
of which can result in base changes during DNA replication if left
unrepaired [22,65–67]. Guanine-protein crosslinks may also lead
to SBSs [68].
GpA, which we confirmed to be a key mutation hotspot
[6,8,9,21,61,63] and found to be enriched in sporadically clustered
non-synonymous substitutions (Table S10), would therefore yield
mutations through electron transfer [36,37,42,69], tissue-specific
deamination [33] and photoexcitation, leading to cyclobutane
pyrimidine dimers (CPDs) in melanoma [10,11]. We also
identified NGRA, and to a lesser extent NGRG, sequences as
mutation hotspots specific to melanoma. Attempts to determine
whether mutations at NGRA might have been caused by UV-
photosensitization or electron transfer, based on mutation spectra
analyses (see Introduction), were uninformative since base
substitution patterns were heavily sequence-context dependent.
For example, in the context of these melanoma datasets, P2-G in
the TGTT motifs underwent GRA:GRT substitutions in the
relative proportions 17:75, whereas for the TGCC motifs this ratio
was 81:13. Hence, sequence context determines the outcome of
single base substitution in a manner that still eludes complete
understanding. Nevertheless, if electron transfer reactions were
involved, then P4-A would be expected to exert stronger effects
than P4-G on mutations at P2-G, since hole trapping is much
weaker on adenine than on guanine bases [47].
Figure 3. Germline mutations are affected by transcription. Panel A, HGMD dataset; y-axis, as in Figure 1C; x-axis, ratio of mutated NGNN
sequences in protein coding genes containing the P2-guanine base on the non-transcribed (NT) vs. transcribed (T) strand; solid circles, HGMD dataset
(r2 0.32, P(a)0.05 0.991, P,0.001); open circles, 1000 Genomes Project dataset. Panel B, inherited splicing mutations dataset; top, cartoon of exon-intron
boundaries showing the conserved GT and AG bases at the donor (ds) and acceptor (as) splice sites; bottom, graph of splicing mutations; y-axis,
number of SBSs; x-axis, position of SBSs relative to +/220 nt of splice junctions; Panel C, model for sequence-dependent SBSs in cancer and human
inherited disease. In the first step, an electron is lost from within a tetranucleotide sequence, leaving a hole. In the second step, the hole migrates to
and from various competing sites, including nearby bases and chromatin-associated amino acids (not shown), eventually being trapped by a guanine
base. The resulting guanine radical cation either causes DNA-protein crosslinking or undergoes subsequent chemical modifications. If the modified
base is not corrected by DNA repair, it may give rise to a mutation (X-Y base-pair) as a result of error-prone DNA polymerase synthesis during DNA
replication (dashed arrow).
doi:10.1371/journal.pgen.1003816.g003
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The CpG dinucleotide was found to be a consistent mutational
hotspot, both in cancer and the germline, a result that generalizes
the conclusions drawn from previous studies [4,9,16–18,63]. The
high frequency of CRT transitions at CpG dinucleotides is
generally attributed to high rates of deamination of 5-methylcyt-
osine resulting from methylation of CpG sites [9,19,20,62].
However, other mechanisms have been proposed [60,62], such
as enhanced susceptibility of methylated CpG sites to damage by
physical and chemical genotoxic agents [62]. This latter interpre-
tation would be consistent with our finding that electronic
coupling is an important factor in establishing the hierarchy for
base modification in DNA. During the course of normalizing
mutation fractions by genome mappability, we noted an enrich-
ment of CGNN sequences in Segmental Duplications. Nakken et
al. [70] reported a higher density of CpG islands in Segmental
Duplications than in unique chromosomal regions, whereas Xie et
al. found methylation-associated SNP clusters to be more
prevalent in Segmental Duplications than in unique regions
[71]. Thus, the prevalence of CGNN-associated SBSs may well be
greater than our study indicates.
A confounding factor in our analyses is the relatively small
number of SBSs, particularly in EWS datasets, which caused large
variations in fi values. Indeed, three of the four datasets that
displayed high-confidence (i.e. P,0.05 and P(a)0.05.0.800) corre-
lations between SBSs and DG(n) or VIPs were obtained from
genome-wide studies. Combining all fi values into a single group
(Figure S2, Panel D) only alleviates the problem, since the fi values
for each dataset are given the same weight. Nevertheless, the
ensuing ‘‘cautiously significant correlation’’ is consistent with a role
for electronic coupling in cancer-related mutagenesis. A second
confounding factor is the multiple roles that the GpA dinucleotide
plays in mutagenesis, as eluded to earlier. In the case of
melanomas, if the numbers of mutated NGAN (and NGA)
sequences were dominant, this might cause chance correlation
with DG(n) or VIP values, when in fact most mutations could arise
from CPDs on the complementary strand. Correlations for both
the Melanoma_gws and Melanoma_ews datasets remained highly
significant (P,0.002; P(a)0.05 0.920–1.000) when the fi values for
the NGAN (or NGA) sequences were excluded from the analyses,
thereby confirming a role for charge transfer. This conclusion is
further supported by the observation that electronic coupling and
photo-induced energy transfer reactions at pyrimidine dimers
occur simultaneously and impinge on one another [72–74].
In cancer, the subset of mutational changes resulting from NS
substitutions that recurred in different patient samples displayed
the same enrichment of mutations at CpG and GpA sequences as
the exome-wide and genome-wide sequence alterations, support-
ing the notion of common underlying causes, i.e. cytosine
methylation, electron transfer (this study), enzymatic cytosine
deamination and CPD formation (in melanoma) [10,11,17]. These
commonalities suggest that the mechanisms involved in generating
‘‘driver’’ tumor initiating mutations are likely to be similar to those
involved in generating the bulk of subsequent ‘‘passenger’’
mutations. Hodis et al. [75] reached a similar conclusion using a
quite different approach. Thus, electron transfer appears to be
involved in both the early (driver mutations) and late (passenger
mutations) phases of tumorigenesis, particularly in tissues of
epithelial origin. Recurrent NS substitutions were observed
predominantly in gene networks associated with p53 function in
all tumor types, the exception being melanoma where a
preponderance of mutations at GpA segregated with genes of
the MAP kinase signaling pathway. The reason for this distinction
remains unclear; however, the critical role played by the MAP
kinase signaling pathway in melanocyte proliferation in response
to UV damage [76] suggests that positive selection may have been
a contributory factor.
The results of the HGMD data analysis support the occurrence
of electron transfer in germline mutagenesis associated with
human inherited disease, although sequence context-dependent
mutagenesis was evident only when mutations were mapped onto
the non-transcribed strands of genes. Guanines modified by
oxidative DNA damage are repaired predominantly by base
excision repair (BER) [77,78]. Since oxidative DNA damage
occurs more efficiently in single-stranded DNA than in double-
stranded DNA [79,80], oxidative guanine lesions may have
formed more frequently on the single-stranded, non-transcribed,
strand than on the DNA:RNA duplex during transcription. Thus,
a greater number of lesions would be expected to escape BER on
the non-transcribed strand than on the transcribed strand. In
cancer cells, the large number of mutations that generally
accumulate during tumor growth could have masked this bias.
An alternative or additional possibility is that transcription-
coupled nucleotide excision repair, a mechanism that processes
bulky DNA adducts and which selectively corrects errors on the
transcribed DNA strand [81], might have contributed to the
strand asymmetric mutations observed in the HGMD dataset
[9,11,12,82,83]. In similar vein, we interpret the selectivity of
mutations at purines on the non-transcribed strands of splice
junctions as a consequence of oxidative damage, whose effect
could have been prolonged by the pausing of transcription-
coupled splicing at splice junctions [84]. With the number of
sequenced genomes rapidly increasing, it will be of great interest to
ascertain whether electron transfer constitutes a general muta-
tional mechanism that is common to all forms of life.
Materials and Methods
Datasets
We collected the publicly available data from cancer genome
studies reported in PubMed from 2007 through December 2011
[1–15] together with the 5 largest datasets available from the
International Cancer Genome Consortium (ICGC). The cancer
genome datasets varied widely in terms of sequencing strategies,
mapping techniques and variant-calling algorithms, implying that
the power to detect SBSs may differ depending upon the datasets
and methodologies used [85]. However, all studies excluded base
variants present in matched-control tissues, such that the reported
SBSs were changes attributed to somatic mutations in the tumor
tissue. Matched controls were used for all patient samples. On
average, between 6 [15] and 1834 [1] tumor-specific SBSs were
reported in the EWS studies (between 1012 [3] and .50,000 [8]
in the GWS studies) (Table 1), which is ,1–3 orders of magnitude
lower than the numbers of non-synonymous and splice-site
variants noted on average in whole-exome studies [86]. In
addition to normal-tumor matched samples, single nucleotide
polymorphisms present in dbSNP databases or in the Venter and
Watson genomes [1,10,11] were also used to exclude common
base variants. Differences in variant-calling power were mitigated
in our study since we examined relative proportions of mutated
sequences, rather than absolute mutation fractions.
A second source of variation in detecting SBSs among the
cancer genome studies was the sequencing instrument used.
Illumina sequencers have been reported to yield systematic base-
call errors, especially at the last base of context-specific GGC and
GGT sequences, which affect either the forward or reverse strand,
and at inverted repeats [87,88]. The sequencing technologies
employed included Illumina genome analyzers, SOLiD next-
generation DNA sequencing, ion semiconductor sequencing,
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dubbed cPAL (combinatorial probe-anchor ligation) nanoballs,
capillary electrophoresis, 454 pyrosequencing and mass spectrom-
etry, often used in combination to verify variant calling. Illumina
sequencers were the most commonly instruments employed in the
studies whose data we used [1,3,4,6,7,10–14]. The frequency of
such base-call errors has been estimated at ,0.1–0.3% before
filtering, and even lower after filtering (SAMtools) [87]. Consid-
ering that sequencing errors tend to occur over long simple repeat
tracts, which have low mappability, and that systematic errors at
GGT were ignored (we analyzed mutations at GNC bps only), it
seems unlikely that base-call errors have biased our analyses by
.0.1%, an acceptable limit.
Mappable Mutations
Approximately half of the human genome sequence comprises
highly homologous repetitive DNA elements (Alu repeats, LINE
elements etc.) and simple repeats, and an additional ,3.6%
contains Segmental Duplications, i.e. segments of .1 kb in length
that are present at multiple loci and which share ,90–98%
sequence similarity (http://genome.ucsc.edu). Thus, because only
the mappable genome may be scored for mutations, we used
various methods to estimate the total number of mappable
NGNN sequences to use as denominators in the fi fractions (see
below). Three methods were used for the GWS studies: 1) the
entries with a mappability index of 1 (representing unique
sequences) from file wgEncodeDukeMapabilityUnique-
ness35bp.bigWig (http://hgdownload.soe.ucsc.edu/goldenPath/
hg19/database/) generated for the ENCODE project by the Duke
University Institute for Genome Sciences and Policy (IGSP) and at
the European Bioinformatics Institute (EBI), which we refer to as
Duke35; 2) we selected sequences from the mappability file
wgEncodeCrgMapabilityAlign50mer.bw ((http://hgdownload.soe.
ucsc.edu/goldenPath/hg19/database/) [89] (Donohue et al.,
unpublished data), referred to as CRG50; and 3) we retrieved all
NGNN sequences in the GRCh37/hg19 release of the human
genome assembly (chromFa.tar.gz file at http://hgdownload.soe.
ucsc.edu/goldenPath/hg19/bigZips/) (T_hg19).
For the EWS studies, the SureSelect Human All Exon Kit
(http://www.genomics.agilent.com) was the most common plat-
form reported [2,4,7,13]. A custom RefSeq CCDS PCR primer
library was used to generate the Glioblastoma dataset [5] and a set
of 1,507 genes (oncogenes, tumor suppressors, ‘‘druggable
targets’’) were targeted in the Mixed cancer dataset [15]. Hence,
three methods were used to estimate the number of mappable
NGNN sequences in the EWS studies: i.e. the NGNN counts from
1) the file S0293689_Covered.bed (http://www.Agilent.com),
listing the coordinates of exons targeted by the SureSelect Human
All Exon Kit (AgilentV2); 2) the RefSeq exons sequences of




We defined fi = mi/ti, where mi was the number of mutations at a
specific NGNNNNNCN sequence (henceforth designated as
NGNN) and ti was the total number of that sequence in one of
the six ‘‘mappable’’ sets described above. The total number of
NGNN sequences was doubled for the self-complementary
AGCT, CGCG, GGCC and TGCA sequences since, like all
NGCN sequences, they contain two mutations sites, one on the
forward and one on the reverse strand. In relation to the counts of
mutated NGNN motifs, if the .G.. occurred at the same genomic
coordinate more than once within a cancer dataset, or if it was a
homozygous mutation, it was considered as one count. Custom
shell and FORTRAN scripts were used to obtain the total
numbers of mappable NGNN and fi fractions (see Text S1 for
sample scripts). The normalized fractions of mutated DGNN
sequences were defined as Fi = fi/gfi, thus, gFi scaled to 1. N
indicates any base (A/C/G/T); D indicates A/G/T; B indicates
C/G/T. As mentioned, sequence designation implies double-
stranded DNA (i.e. AGTC = (59-AGTC-39)N(59-GACT-39)). The
average base stacking free energies ,DG(n). were obtained from
Friedman and Honig [51] by using the DG(n) (ei = 2) values for the
three base steps (DpG + GpN + NpN)/3. The free energy of base
stacking DG(n) is an estimate of the absolute contribution of base
stacking to nucleic acid stability in the absence of hydrogen
bonding interactions, and contains a contribution from nonpolar
plus electrostatic forces, as assessed from a theoretical approach
using the Amber force field and a continuum solvation model of
water. The largest contribution to DG(n) was found to arise from
nonpolar [51], as opposed to electrostatic, interactions. Nonpolar
interactions were contributed for the most part by enhancement in
the Lennard-Jones component as a result of close packing, and to a
smaller extent from hydrophobic interactions. Thus, the DG(n)
values follow the same trend as the nonpolar contributions to free
energies of base stacking DGnp(n), i.e. purine-purine .. purine-
pyrimidine . pyrimidine-purine . pyrimidine-pyrimidine, in
qualitative agreement with experimental determinations [51]. The
relative enrichment E of sequence i, Ei, was defined as the ratio
Di/Ti, where Di = di/gdi, di being the number of times sequence i
was mutated at least twice at the same hg19 coordinate and Ti = ti/
gti, ti being the total number of occurrences of sequence i exome-
wide (T_exons). Finally, S = sn/gsn and sn = tn/cn, tn being the
number of times the combined (top) sequences were recurrently
mutated and cn being the total number of NS substitutions in a
particular type of cancer.
Molecular Modeling
Three-dimensional structures of the 12 possible double-stranded
DGN trinucleotides were constructed using w3DNA [90].
Hydrogen atoms, atomic charges and four neutralizing Na+
counterions were assigned to each sequence according to the
amber99 force field [91], using UCSF CHIMERA [92]. Na+
counterions were positioned next to the four DNA backbone
phosphates. Each trinucleotide was energy minimized in vacuo
using the 10,000 steps steepest descent algorithm and the amber99
force field in GROMACS 4.5.1 [93]. Ten and 14 Å cutoffs were
used for Coulomb and van der Waals interactions, respectively.
Vertical Ionization Potentials (VIPs)
VIPs were computed using Kohn-Sham density functional
theory (DFT) [94] employing the Minnesota M06-26 functional
[95,96] with all-electron 6–31G(d) basis sets [97,98], as imple-
mented in the GAMESS electronic structure package [99], and
including backbone phosphate groups and sodium counter ions in
addition to the DGN double-stranded bases. The M06-26
functional was used since this method provides accurate descrip-
tions of hydrogen bonding and stacking interactions between base-
pairs. We reasoned that the DGN set would provide the same type
of information as the computationally more demanding NDGN
set. Molecular orbitals were depicted using the MacMolPlt
graphics program [100].
Pathway Analysis
For individual patient samples, mutations were collated and
sorted into lists of genes carrying mutations using customized R
scripts (http://www.r-project.org/). The gene lists for each sample
were entered into our pattern extraction pipeline analysis (PPEP)
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[101], as implemented in the WPS package [102], to obtain the
ListHit of genes (number of genes from each list that are annotated
to each pathway) for each of the BioCarta pathways. For each
tumor type, each pathway was ranked on the basis of how
frequently it was ‘‘hit’’ by individual patient samples and the
ranking scores were obtained as the percentages of patient samples
that had at least one hit in the corresponding pathway, using
customized R scripts. The tumor type ranking scores for each
pathway were combined and used to rank the pathways for all
tumor types. The highest ranked pathways represent the most
‘‘popularly’’ hit pathways amongst all types of tumors. For each
highly ranked pathway, the genes carrying the mutations were
retrieved from each patient sample, ranked and displayed as gene-
level heatmaps. For the pathway analysis of recurrent NS
substitutions, the relevant genes for each tumor type were collated
into lists and subjected to PPEP analysis, as described above.
Hierarchical Clustering
Agglomerative hierarchical clustering dendrograms [103] were
built using either the regression coefficients, r, between the
fractions of mutated DGN sequences, f(DGN), and the VIP
values, or the absolute orthogonal distances (Manhattan distances)
between each f(NGNN) data point for all datasets. All-to-all
comparisons were performed, allowing the relative estimation of
all components of the systems, including the reference VIP branch.
Supporting Information
Figure S1 Individual samples from the same cancer dataset and
cancer types share mutational patterns. Panel A, analysis of
variance for the normalized fractions of CGNN vs. DGNN and
DGRN vs. DGYN for the 14 Melanoma_ews samples computed
from the AgilentV2 mappability counts; full circles, Holm-Sidak test
on the difference of means (normality test by Shapiro-Wilk,
P = 0.657); triangles, Kruskal-Wallis one-way ANOVA on ranks
(H = 18.66). Panel B, hierarchical clustering of the 20 largest
datasets (Table 1) plus 5 individual samples comprising the
Pancreatic_ca dataset, computed from the sum of the absolute
difference (Manhattan distance) in the scaled frequencies of
mutated NGN trinucleotides obtained by summing the 4th
positions of the NGNN frequencies. Mutated frequencies for the
NGNN sequences were according to Duke35 (GWS) and
AgilentV2 (EWS) counts.
(TIF)
Figure S2 Plots of the correlation between f(DGN) and VIPs. x-
axis, normalized mutations fractions; y-axis, VIP values; Panel A, fi
for Melanoma_ews computed using the AgilentV2 mappability
counts; Panels B and C, fi for the Melanoma_gws and Liver_riken,
respectively, computed using the Duke35 mappability counts;
Panel D, averaged fi values for 18 cancer datasets (Table S6). See
Legend to Fig. 1 for details.
(TIF)
Figure S3 Genes with NS substitutions and mutation spectrum.
Panel A. Plot of the number of NS substitutions per 100 amino
acids (H) for the 29 genes in the combined cancer datasets with
$24 NS substitutions. Panel B, as in Panel A, for genes with $4
recurrent NS substitutions; dotted line, median protein size in amino
acid residues, as derived from http://www.genecards.org/. Panel
C, percentage of the six possible types of SBS for the 35,480 NS
substitutions in the combined cancer genomes.
(TIF)
Figure S4 Pathway-level heatmaps. Panel A, pathway-level
heatmap for the highest-ranking (from top down) pathways
(www.biocarta.com) based on the ‘‘fractional representation’’ of
genes hit by NS substitutions across all combined individual
patient samples for all tumor types. Rows, pathways; columns: tumor
types; Fractional representation, color-gradient of the fraction of
patient samples in each tumor type that have at least one gene-hit
in the corresponding pathway. Panel B, patient sample-specific
pathway-level heatmap. Gene-level heatmap displaying the
individual patient samples (rows) carrying NS substitutions in
genes belonging to a common pathway (columns) ranked in order of
their ‘‘popularity’’ for the top pathways shown in Panel A. Panel C,
Telomeres-Aging term gene-level heatmap. The detailed gene-
level heatmap for the top pathway ‘‘Telomeres-Aging’’ shown in
Panel B. Columns: individual patient samples arranged by tumor
types; rows: genes hit by NS substitutions ranked in order of
number of mutations.
(TIF)
Figure S5 Nucleotide conservation and variation at splice
junctions. Top panel, fractional conservation within +/225 nt in
295,093 unique donor and acceptor splice junctions from
annotated genes in the GRCh37/hg19 human genome assembly.
Middle panel, number of single nucleotide variants (SNV) in the ‘‘rs’’
set of the 1000 Genomes Project, mapped as shown in the top
panel. Bottom panel, number of SBSs in the TCGARN cancer
dataset mapping to the splice junctions shown on the top panel.
(TIF)
Table S1 NGNN counts and relative abundance in the whole
genome and the mappable genome. Panel A, whole genome; Panel
B, exome; raw NGNN counts, number of NGNN sequences in each
set; relative NGNN percentage, raw numbers divided by total 6100;
grouping, relative percentages for CGNN, DGNN, NGNN
containing at least 3 guanines (3G), DGRN and DGYN; comparison
between sets, values obtained from setA/setB*100-100.
(XLSX)
Table S2 Statistical significance of NGNN representation in
mappable genome and exome. Two-tailed t-tests for the
‘‘comparison between sets’’ data from Table S1.
(DOCX)
Table S3 List of chromosomal positions (GRCh37/hg19)
affected by SBSs in the cancer datasets. Only non-redundant
positions within each dataset are recorded.
(XLSX)
Table S4 fi fractions and associated statistics. Panel A, counts of
SBSs occurring at each NGNN sequence in all datasets and ratios
of SBSs affecting GNC base-pairs; Panel B, fi fractions for the GWS
datasets according to three methods and associated statistics (two-
tailed paired t-test); Panel C, fi fractions for the EWS datasets
according to three methods and associated statistics (two-tailed
paired t-test); Panel D, fi fractions for the 2 small EWS datasets
(Colorectal_1 and Colorectal_2) and the 14 Melanoma_ews
samples according to three methods and associated statistics (z-
test; P(a)0.05 statistics); Panel E, chromosomal positions and counts
of SBSs occurring at each NGNN sequence in the 14 patient
samples from the Melanoma_ews dataset (*T series) and in the 5
patient samples from the Pancreatic_ca dataset (PCSI* series).
(XLSX)
Table S5 fi fractions for NGNN sequences with P3-A or P3-B
(C/G/T) in melanomas. Statistical analyses, two-tailed t-tests.
(DOCX)
Table S6 Normalized mutation fractions at NGRN sequences in
melanoma. EWS or GWS f(NGRN) fractions within each dataset
were normalized by dividing for f(CGAA), which displayed the
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highest value in all datasets. fi fractions were computed using the
T_hg19 and T_exons counts. Green background, the 8 combinations
of the NGRA sequence; tan background, f(NGRB) values that were
lower than the corresponding f(NGRA) values; turquoise background,
f(NGRB) values that were higher than the corresponding f(NGRA)
values; Wei, [10]; Pleasance, [11]; Berger, [17]; Nikolaev, [21]; Stark,
[40]; Krauthammer, [34].
(DOCX)
Table S7 Correlations with free energy of base stacking and
VIPs. Panel A, correlations of ln[f(DGNN)] values with free energies
of base stacking; Panel B, correlations of ln[f(DGN)] values with
VIPs. For the combined datasets, the fractions were normalized. fi
values were computed using the Duke35 (GWS) and AgilentV2
(EWS) mappability counts.
(DOCX)
Table S8 Fractional representation of genes with NS substitu-
tions across cancer tissue types and their Aggregate Score. List of
genes found to contain non-synonymous substitutions and their
combined fractional representation, expressed as Aggregate Score,
across cancer types.
(XLSX)
Table S9 Recurrent NS substitutions and driver mutations.
Hg19 coordinates containing the largest number of recurrent NS
substitutions for various types of motifs and their potential as
driver mutations; 1 sequences are reported with the mutated base
(A or G) at P2; 2 support from PubMed for a driver mutation
following searches for ‘‘gene_name & mutated_codon’’ or
‘‘gene_name & cancer’’ and a manual review of the articles
found: *** mutated codon that has been reported as a driver
mutation; ** (!) mutated codon in p53 that has not been reported
to harbor a driver mutation; ** strong support for gene mutation
or change in gene expression being involved in tumorigenesis; *
weak support for gene mutation or change in gene expression
being involved in tumorigenesis; unk, insufficient information to
assess whether a gene mutation or change in gene expression was
involved in tumorigenesis.
(DOCX)
Table S10 Individual patient samples harboring genes with $4
NS substitutions. Sequence context-dependency of patient samples
which experienced $4 NS substitutions in the same gene. White
background, SBSs at DGNN sequences; white on black background,
SBSs at CGNN sequences; gray background, SBSs at NANN
sequences; bold, SBSs at DGRN sequences. Fraction of NGNN
sequences: 30/35 = 86%).
(DOCX)
Text S1 Supporting information. The text contains information
on the distribution of NGNN sequences in the mappability files
and in Segmental Duplications, a description of mutational
mechanisms shared by similar cancer types and individual
samples, the analysis of recurrent non-synonymous substitutions,
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